Hillsdale Investment Management’s Harmony Biosciences HRMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.81M | Buy |
120,700
+50,500
| +72% | +$1.6M | 0.14% | 207 |
|
|
2025
Q1 | $2.33M | Buy |
70,200
+2,200
| +3% | +$73K | 0.12% | 199 |
|
|
2024
Q4 | $2.34M | Buy |
68,000
+300
| +0.4% | +$10.3K | 0.12% | 205 |
|
|
2024
Q3 | $2.71M | Buy |
67,700
+900
| +1% | +$36K | 0.21% | 177 |
|
|
2024
Q2 | $2.02M | Sell |
66,800
-2,800
| -4% | -$84.5K | 0.16% | 194 |
|
|
2024
Q1 | $2.34M | Buy |
69,600
+5,700
| +9% | +$191K | 0.18% | 180 |
|
|
2023
Q4 | $2.06M | Sell |
63,900
-300
| -0.5% | -$9.69K | 0.17% | 182 |
|
|
2023
Q3 | $2.1M | Hold |
64,200
| – | – | 0.19% | 170 |
|
|
2023
Q2 | $2.26M | Sell |
64,200
-11,400
| -15% | -$401K | 0.21% | 160 |
|
|
2023
Q1 | $2.47M | Hold |
75,600
| – | – | 0.21% | 144 |
|
|
2022
Q4 | $4.17M | Buy |
+75,600
| New | +$4.17M | 0.35% | 110 |
|